Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074.
Kathryn Elizabeth LancasterKatie R MollanBrett S HanscomBonnie E Shook-SaTran V HaKostyantyn DumchevZubairi DjoerbanScott M RoseCarl A LatkinDavid S MetzgerVivian F GoSergii DvoriakSarah A ReifeisEstelle M Piwowar-ManningPaul RichardsonMichael G HudgensErica L HamiltonSusan H EshlemanHepa SusamiViet Anh ChuSamsuridjal DjauziTetiana KiriazovaDo Thi NhanDavid N BurnsWilliam C MillerIrving F HoffmanPublished in: Open forum infectious diseases (2021)
Viral suppression declined in year 2 for those who initially received the HPTN 074 intervention and improved maintenance support is warranted. Viral suppression and MOUD increased among in need participants who received intervention during the study extension. Continued efforts are needed for widespread implementation of this scalable, integrated intervention.